What AI says about Nitto Avecia

Nitto Denko Avecia provides comprehensive oligonucleotide solutions from preclinical manufacturing to drug substance production. Its experts develop and validate safe, robust, and cost-effective processes to advance oligonucleotide programs.

AI named Nitto Avecia from December 2025 to January 2026.

Markets